Cited by 674Psychedelics and Drug StudiesPosttraumatic Stress Disorder ResearchElectroconvulsive Therapy Studies

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

Open access

Mithoefer, Michael C, Wagner, Mark T, Mithoefer, Ann T, Jerome, Lisa, Doblin, Rick·2011·Journal of Psychopharmacology

DOI 10.1177/0269881110378371PMC PMC3122379

Open this paper in CoChat — free account

Abstract

Case reports indicate that psychiatrists administered ±3,4-methylenedioxymethamphetamine (MDMA) as a catalyst to psychotherapy before recreational use of MDMA as 'Ecstasy' resulted in its criminalization in 1985. Over two decades later, this study is the first completed clinical trial evaluating MDMA as a therapeutic adjunct. Twenty patients with chronic posttraumatic stress disorder, refractory to both psychotherapy and psychopharmacology, were randomly assigned to psychotherapy with concomitant active drug (n = 12) or inactive placebo (n = 8) administered during two 8-h experimental psychotherapy sessions. Both groups received preparatory and follow-up non-drug psychotherapy. The primary outcome measure was the Clinician-Administered PTSD Scale, administered at baseline, 4 days after each experimental session, and 2 months after the second session. Neurocognitive testing, blood pressure, and temperature monitoring were performed. After 2-month follow-up, placebo subjects were offered the option to re-enroll in the experimental procedure with open-label MDMA. Decrease in Clinician-Administered PTSD Scale scores from baseline was significantly greater for the group that received MDMA than for the placebo group at all three time points after baseline. The rate of clinical response was 10/12 (83%) in the active treatment group versus 2/8 (25%) in the placebo group. There were no drug-related serious adverse events, adverse neurocognitive effects or clinically significant blood pressure increases. MDMA-assisted psychotherapy can be administered to posttraumatic stress disorder patients without evidence of harm, and it may be useful in patients refractory to other treatments.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1177/0269881110378371

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
Emotional processing of fear: Exposure to corrective information.
Foa, E. B., & Kozak, M. J. (1986) · Psychological Bulletin · doi:10.1037/0033-2909.99.1.20 · Cited by 5,396
Combat Duty in Iraq and Afghanistan, Mental Health Problems, and Barriers to Care
Hoge, C. W., Castro, C. A., Messer, S. C., McGurk, D., Cotting, D. I., & Koffman, R. L. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040603 · Cited by 4,778
Oxytocin increases trust in humans
Kosfeld, M., Heinrichs, M., Zak, P. J., Fischbacher, U., & Fehr, E. (2005) · Nature · doi:10.1038/nature03701 · Cited by 3,690
The Impact of Event Scale: Revised
Weiss, D. S. (2007) · Springer eBooks · doi:10.1007/978-0-387-70990-1_10 · Cited by 3,074
The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity
Randolph, C., Tierney, M. C., Mohr, E., & Chase, T. N. (1998) · Journal of Clinical and Experimental Neuropsychology · doi:10.1076/jcen.20.3.310.823 · Cited by 2,519
Paced Auditory Serial-Addition Task: A Measure of Recovery from Concussion
Gronwall, D. M. A. (1977) · Perceptual and Motor Skills · doi:10.2466/pms.1977.44.2.367 · Cited by 2,395
Clinician-administered PTSD scale: A review of the first ten years of research
Weathers, F. W., Keane, T. M., & Davidson, J. R. T. (2001) · Depression and Anxiety · doi:10.1002/da.1029 · Cited by 1,903
Invisible Wounds of War: Psychological and Cognitive Injuries, Their Consequences, and Services to Assist Recovery
Adamson, D. M., Burnam, M. A., Burns, R. M., Caldarone, L. B., Cox, R. A., D’Amico, E. J., Díaz, C., Eibner, C., Fisher, G., Helmus, T. C., et al. (2008) · RAND Corporation eBooks · doi:10.7249/mg720 · Cited by 1,713
Effective Treatments for PTSD
Freeman, A. M. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1112 · Cited by 1,667

Show all 67 references

Research works printed but not linked: 14

Breslau N, 2001, J Clin Psychiatry, 62, 16
Cloitre M, 2009, CNS Spectr, 14, 32
Committee on Treatment of Posttraumatic Stress Disorder, Institute of Medicine, 2008, Posttraumatic stress disorder: an assessment of the evidence
Derogatis LR, 1994, SCL-90-R: Administration, Scoring and Procedures Manual
First MB, 1997, Structured clinical interview for Axis II DSM-IV disorders: Patient Edition (SCID II)
First MB, 1994, Structured clinical interview for Axis I DSM -IV disorders: Patient Edition (SCID-I/P)
Grof S, 2000, Psychology of the Future
Ipser J, 2006, S Afr Med J, 96, 1088
Metzner R, 2001, Ecstasy: the complete guide, 182
Ogden PKM, 2006, Trauma and the body
Pahnke WN, 1971, Int J Clin Pharmacol, 4, 446
Stein DJ, 2009, CNS Spectr, 14, 25
10.1038/sj.npp.1395197 · DOI · Paper page
Wilbarger P, 1997, Sensory defensiveness and related social/emotional and neurological problems

Sorted by citations

Items 301–400 of 671

A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment
Burdick, B. V., & Adinoff, B. H. (2013) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2013.811513 · Cited by 19
Social Work and Psychedelic-Assisted Therapies: Practice Considerations for Breakthrough Treatments
Hutchison, C. A., & Bressi, S. (2020) · Clinical Social Work Journal · doi:10.1007/s10615-019-00743-x · Cited by 17
3,4-Methylenedioxymethamphetamine’s (MDMA’s) Impact on Posttraumatic Stress Disorder
White, C. M. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014532236 · Cited by 18
(2-Aminopropyl)benzo[β]thiophenes (APBTs) are novel monoamine transporter ligands that lack stimulant effects but display psychedelic-like activity in mice
Rudin, D., McCorvy, J. D., Glatfelter, G. C., Luethi, D., Szöllősi, D., Ljubišić, T., Kavanagh, P. V., Dowling, G., Holy, M., Jäntsch, K., et al. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01221-0 · Cited by 17
Clinically Relevant Pharmacological Strategies That Reverse MDMA-Induced Brain Hyperthermia Potentiated by Social Interaction
Kiyatkin, E. A., Ren, S. E., Wakabayashi, K. T., Baumann, M. H., & Shaham, Y. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.182 · Cited by 17
Technology, Design and the Arts - Opportunities and Challenges
Earnshaw, R., Liggett, S., Excell, P. S., & Thalmann, D. (2020) · Springer series on cultural computing · doi:10.1007/978-3-030-42097-0 · Cited by 17
Augmentation of Psychotherapy with Neurobiological Methods: Current State and Future Directions
Hertenstein, E., Trinca, E., Schneider, C. L., Wunderlin, M., Fehér, K. D., Riemann, D. W., & Nissen, C. (2021) · Neuropsychobiology · doi:10.1159/000514564 · Cited by 15
Evidence on the impairing effects of Ayahuasca on fear memory reconsolidation
Daneluz, D. M., Sohn, J. M. B., Silveira, G. D. O., Yonamine, M., & Stern, C. A. J. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06217-2 · Cited by 17
A survey of Australian psychiatrists’ and psychiatry trainees’ knowledge of and attitudes towards psychedelics in the treatment of psychiatric disorders
Grover, C., Monds, L. A., & Montebello, M. E. (2023) · Australasian Psychiatry · doi:10.1177/10398562231155125 · Cited by 16
Are ecstasy induced serotonergic alterations overestimated for the majority of users?
Szigeti, B., WINSTOCK, A. R., Erritzøe, D., & Maier, L. J. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118767646 · Cited by 16
Methamphetamine regulates βAPP processing in human neuroblastoma cells
Shukla, M., Maitra, S., Hernandez, J., Govitrapong, P., & Vincent, B. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.02.023 · Cited by 16
Effects of Selective Serotonin Reuptake Inhibitor Use on 3,4-Methylenedioxymethamphetamine–Assisted Therapy for Posttraumatic Stress Disorder
Price, C. M., Feduccia, A. A., & DeBonis, K. (2022) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001595 · Cited by 17
MDMA for the treatment of mood disorder: all talk no substance?
Patel, R., & Titheradge, D. (2015) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125315583786 · Cited by 17
MDMA-assisted psychotherapy for borderline personality disorder
Traynor, J. M., Roberts, D. E., Ross, S., Zeifman, R., & Choi-Kain, L. (2022) · Focus · doi:10.1176/appi.focus.20220056 · Cited by 15
Novel Pharmacologic and Other Somatic Treatment Approaches for Posttraumatic Stress Disorder in Adults: State of the Evidence
Sippel, L. M., Hamblen, J. L., Kelmendi, B., Alpert, J. E., Carpenter, L. L., Grzenda, A. L., Kraguljac, N. V., McDonald, W. M., Rodríguez, C. I., Widge, A. S., et al. (2024) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230950 · Cited by 15
Blinding Integrity in Psychedelic Randomized Clinical Trials
Orsini, D. K., Wong, S., Luch, S. D. D., Chan, B., Vasudeva, S., Lovell, G. F. M., Le, G. H., Jones, B. D. M., Chisamore, N., Mollica, A., et al. (2026) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2026.0255 · Cited by 19
3,4-Methylenedioxymethamphetamine as a Psychiatric Treatment
Bedi, G. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0063 · Cited by 15
Single oral doses of (±) 3,4-methylenedioxymethamphetamine (‘Ecstasy’) produce lasting serotonergic deficits in non-human primates: relationship to plasma drug and metabolite concentrations
Mueller, M., Yuan, J., McCann, U. D., Hatzidimitriou, G., & Ricaurte, G. A. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000582 · Cited by 14
Embracing Neurodiversity in Psychedelic Science: A Mixed-Methods Inquiry into the MDMA Experiences of Autistic Adults
Danforth, A. L. (2019) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2019.1587116 · Cited by 15
MDMA enhances pleasantness of affective touch
de Wit, H., & Bershad, A. K. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0473-x · Cited by 15
No major role of norepinephrine transporter gene variations in the cardiostimulant effects of MDMA
Vizeli, P., zu Schwabedissen, H. E. M., & Liechti, M. E. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2392-2 · Cited by 16
Acute effects of MDMA on autonomic cardiac activity and their relation to subjective prosocial and stimulant effects
Clark, C. M., Frye, C. G., Wardle, M. C., Norman, G. J., & de Wit, H. (2014) · Psychophysiology · doi:10.1111/psyp.12327 · Cited by 15
Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies
Weleff, J., Akiki, T. J., & Barnett, B. S. (2022) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2022.2133757 · Cited by 14
A Systematic Review of the Neurocognitive Effects of Psychedelics in Healthy Populations: Implications for Depressive Disorders and Post-Traumatic Stress Disorder
Velit-Salazar, M. R., Shiroma, P. R., & Cherian, E. (2024) · Brain Sciences · doi:10.3390/brainsci14030248 · Cited by 14
Gene expression analysis indicates reduced memory and cognitive functions in the hippocampus and increase in synaptic reorganization in the frontal cortex 3 weeks after MDMA administration in Dark Agouti rats
Petschner, P., Tamási, V., Ádori, C., Kirilly, E., Andó, R. D., Tóthfalusi, L., & Bagdy, G. (2018) · BMC Genomics · doi:10.1186/s12864-018-4929-x · Cited by 15
Self-Experiments with Psychoactive Substances: A Historical Perspective
Passie, T., & Brandt, S. D. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_177 · Cited by 14
High ambient temperature facilitates the acquisition of 3,4-methylenedioxymethamphetamine (MDMA) self-administration
Aarde, S. M., Huang, P.-K., & Taffe, M. A. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.10.008 · Cited by 14
Posttraumatic Stress Disorder After a Psychedelic Experience, a Case Report
Rubin-Kahana, D. S., Hassan, A. N., & Foll, B. L. (2020) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000734 · Cited by 14
Electrophysiological Actions of Synthetic Cathinones on Monoamine Transporters
Solis, E. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_39 · Cited by 14
The spurious relationship between ecstasy use and neurocognitive deficits: A Bradford Hill review
Amoroso, T. (2018) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2018.11.002 · Cited by 17
The acute toxic and neurotoxic effects of 3,4-methylenedioxymethamphetamine are more pronounced in adolescent than adult mice
Chitre, N. M., Bagwell, M. S., & Murnane, K. S. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112413 · Cited by 14
Perceived key change phenomena of MDMA-assisted psychotherapy for the treatment of severe PTSD: an interpretative phenomenological analysis of clinical integration sessions
Godes, M., Lucas, J., & Vermetten, E. H. G. J. M. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.957824 · Cited by 12
Bioisosteric analogs of MDMA : Improving the pharmacological profile?
Alberto‐Silva, A. S., Hemmer, S., Bock, H. A., da Silva, L. A., Scott, K. R., Kastner, N., Bhatt, M., Niello, M., Jäntsch, K., Kudlacek, O., et al. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16149 · Cited by 13
Role of Serotonin Transporter and Receptor Gene Variations in the Acute Effects of MDMA in Healthy Subjects
Vizeli, P., zu Schwabedissen, H. E. M., & Liechti, M. E. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00590 · Cited by 13
Cardiovascular and temperature adverse actions of stimulants
Docherty, J. R., & Alsufyani, H. A. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15465 · Cited by 13
The Efficacy of Psychedelic-Assisted Therapy in Managing Post-traumatic Stress Disorder (PTSD): A New Frontier?
Mohamed, A., Touheed, S., Ahmed, M., Hor, M., & Fatima, S. (2022) · Cureus · doi:10.7759/cureus.30919 · Cited by 17
A transdiagnostic meta-analysis of acute augmentations to psychological therapy
Nord, C. L., Longley, B. F., Dercon, Q., Phillips, V., Funk, J., Gormley, S., Knight, R., Smith, A., & Dalgleish, T. (2023) · Nature Mental Health · doi:10.1038/s44220-023-00048-6 · Cited by 15
Reported effects of psychedelic use on those with low well-being given various emotional states and social contexts
Mason, N. L., Dolder, P. C., & Kuypers, K. P. C. (2020) · Drug Science Policy and Law · doi:10.1177/2050324519900068 · Cited by 15
The Potential Role of Serotonergic Hallucinogens in Depression Treatment
Psiuk, D., Nowak, E., Cholewa, K., Łopuszańska, U., & Samardakiewicz, M. (2021) · Life · doi:10.3390/life11080765 · Cited by 12
A Review of Interventions for Treatment-Resistant Posttraumatic Stress Disorder
Katz, C., Stein, M. B., Don, J., Seedat, S., & Saree, J. (2011) · InTech eBooks · doi:10.5772/23234 · Cited by 13
A Review of MDMA-Assisted Therapy for Posttraumatic Stress Disorder
Lewis, B. R., & Byrne, K. (2023) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20220088 · Cited by 14
Psychedelic Therapy: A Primer for Primary Care Clinicians—Historical Perspective and Overview
Tabaac, B. J., Shinozuka, K., Arenas, A., Beutler, B. D., Cherian, K. N., Evans, V. D., Fasano, C., & Muir, O. S. (2024) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001727 · Cited by 13
Mechanisms of psilocybin on the treatment of posttraumatic stress disorder
Choi, C. Q., Johnson, D. E., Chen-Li, D. C. J., & Rosenblat, J. D. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241286771 · Cited by 14
Psychedelics as Reemerging Treatments for Anxiety Disorders: Possibilities and Challenges in a Nascent Field
King, F., & Hammond, R. (2021) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20200047 · Cited by 14
MDMA to Treat PTSD in Adults
Latimer, D. R., Stocker, M. D., Sayers, K., Green, J., Kaye, A. M., Abd-Elsayed, A. A., Cornett, E. M., Kaye, A. D., Varrassi, G., Viswanath, O., et al. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4414 · Cited by 12
MDMA does not alter responses to the Trier Social Stress Test in humans
Bershad, A. K., Miller, M. A., & de Wit, H. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4621-x · Cited by 13
Management of Treatment-Resistant Posttraumatic Stress Disorder
Starke, J., & Stein, D. J. (2017) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-017-0130-0 · Cited by 12
MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder: Implications for Social Work Practice and Research
Hutchison, C. A., & Bressi, S. K. (2018) · Clinical Social Work Journal · doi:10.1007/s10615-018-0676-3 · Cited by 13
La funcionalidad política de la “ciencia” prohibicionista: El caso del cannabis y los psicodélicos
Oró, D. P. M., Apud, I., Scuro, J., & Romaní, O. (2020) · Salud Colectiva · doi:10.18294/sc.2020.2493 · Cited by 12
Depressive mood ratings are reduced by MDMA in female polydrug ecstasy users homozygous for the l-allele of the serotonin transporter
Kuypers, K. P. C., de la Torre, R., Farré, M., Xicota, L., Perna, E. B. D. S. F., Theunissen, E. L., & Ramaekers, J. G. (2018) · Scientific Reports · doi:10.1038/s41598-018-19618-1 · Cited by 13
LSD acutely impairs fear recognition and enhances emotional empathy and sociality
Dolder, P. C. (2016) · doi:10.26226/morressier.5785edc6d462b80296c9935b · Cited by 13
Phytochemical interventions for post-traumatic stress disorder: A cluster co-occurrence network analysis using CiteSpace
Gao, B., Qu, Y.-C., Cai, M., Zhang, Y.-Y., Lu, H., Li, H.-X., Tang, Y., & Shen, H. (2023) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2023.06.006 · Cited by 12
Examining the Role of Oxytocinergic Signaling and Neuroinflammatory Markers in the Therapeutic Effects of MDMA in a Rat Model for PTSD
Avgana, H., Toledano, R. S., & Akirav, I. (2024) · Pharmaceuticals · doi:10.3390/ph17070846 · Cited by 11
Global Trends in Psychedelic Microdosing: Demographics, Substance Testing Behavior, and Patterns of Use
Syed, O. A., Petranker, R., Fewster, E. C., Sobolenko, V., Beidas, Z., Husain, M. I., Lake, S., & Lucas, P. (2024) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2024.2424284 · Cited by 11
Beyond psychedelics: set and setting in general psychiatric practice
Kozak, Z., & Miller, C. W. T. (2024) · International Review of Psychiatry · doi:10.1080/09540261.2024.2419662 · Cited by 12
Psychedelic Treatments in Adolescent Psychopharmacology: Considering Safety, Ethics, and Scientific Rigor
Sutherland, I., Ho, M., & Croarkin, P. E. (2025) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2024.0082 · Cited by 11
The intersection of structurally traumatized communities and substance use treatment: Dominant discourses and hidden themes
Williams, I. L. (2015) · Journal of Ethnicity in Substance Abuse · doi:10.1080/15332640.2014.1003671 · Cited by 14
Emerging Psychedelic-Assisted Therapies: Implications for Nursing Practice
Denis-Lalonde, D., & Estefan, A. (2020) · Journal of Mental Health and Addiction Nursing · doi:10.22374/jmhan.v4i1.40 · Cited by 11
Ayahuasca: Between Cognition and Culture
Peláez, I. E. A. (2020) · Publicacions URV eBooks · doi:10.17345/9788484248347 · Cited by 11
Drogen- und Medikamentenabhängigkeit
Kienast, T., Heinz, A., & Soyka, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_50 · Cited by 11
Why Psychiatry Needs 3,4-Methylenedioxymethamphetamine: A Child Psychiatrist's Perspective
Sessa, B. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0531-1 · Cited by 13
Should Australian Psychology Consider Enhancing Psychotherapeutic Interventions with Psychedelic Drugs? A Call for Research
Bright, S. J., & Williams, M. L. (2018) · Australian Psychologist · doi:10.1111/ap.12345 · Cited by 12
A Neuroanatomic and Pathophysiologic Framework for Novel Pharmacological Approaches to the Treatment of Post-traumatic Stress Disorder
Norred, M. A., Zuschlag, Z. D., & Hamner, M. B. (2024) · Drugs · doi:10.1007/s40265-023-01983-5 · Cited by 13
MDMA-assisted therapy is associated with a reduction in chronic pain among people with post-traumatic stress disorder
Christie, D., Yazar‐Klosinski, B., Nosova, E., Kryskow, P., Siu, W., Lessor, D., & Argento, E. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.939302 · Cited by 13
Current Status of Treatment for Posttraumatic Stress Disorder: Focus on Treatments Combining Pharmacotherapy and Cognitive-Behavioral Therapy
Pull, C. N., & Pull, C. B. (2014) · International Journal of Cognitive Therapy · doi:10.1521/ijct.2014.7.2.149 · Cited by 9
Fear expression is suppressed by tyrosine administration
Soranzo, A., & Aquili, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-52610-x · Cited by 10
Psychotherapie mit adjuvanter Gabe von serotonergen psychoaktiven Substanzen – Möglichkeiten und Hindernisse
Majić, T., Jungaberle, H., Schmidt, T. T., Zeuch, A., Hermle, L., & Gallinat, J. (2017) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-0043-103085 · Cited by 10
Theranostic pharmacology in PTSD: Neurobiology and timing
Koek, R. J., & Luong, T. N. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.12.001 · Cited by 10
Psychoactive substances for the treatment of neuropsychiatric disorders
Zhen, Z., Sun, X., Yuan, S., & Zhang, J. (2024) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2024.104193 · Cited by 11
Prolonged Exposure for PTSD in Intensive Outpatient Programs (PE-IOP)
Rauch, S. A. M., ROTHBAUM, B. O., Smith, E. R., & Foa, E. B. (2020) · doi:10.1093/med-psych/9780190081928.001.0001 · Cited by 10
An Interpretative Phenomenological Analysis of the use of psilocybin by veterans with symptoms of trauma
Smith, F. N., Neill, J. C., & Wainwright, V. (2022) · Drug Science Policy and Law · doi:10.1177/20503245221124117 · Cited by 10
No Influence of Dopamine System Gene Variations on Acute Effects of MDMA
Vizeli, P., & Liechti, M. E. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00755 · Cited by 9
The Impact of Posttraumatic Stress Disorder on Pharmacologic Intervention Outcomes for Adults With Bipolar Disorder: A Systematic Review
Russell, S. E., Wrobel, A. L., Skvarc, D., Kavanagh, B. E., Ashton, M. M., Dean, O. M., Berk, M., & Turner, A. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac057 · Cited by 8
Enhancing Fear Extinction: Pharmacological Approaches
Ponomareva, O. Y., Fenster, R. J., & Ressler, K. J. (2023) · Current topics in behavioral neurosciences · doi:10.1007/7854_2023_443 · Cited by 7
Functional brain changes after alternative pharmacological interventions in posttraumatic stress disorder: A systematic review of clinical trials
Lotfinia, S., Afshar, A., Yaseri, A., Olff, M., & Quidé, Y. (2023) · Brain and Behavior · doi:10.1002/brb3.3292 · Cited by 7
Psychedelic-augmented psychotherapy for overcoming traumatic dissociation: A review of neuroscientific and phenomenological evidence
Rougemont-Bücking, A., Guenot, F., Salamin, V., Gothuey, I., Duffour, C., King-Olivier, J., Girard, V., & Naudin, J. (2024) · European Journal of Trauma & Dissociation · doi:10.1016/j.ejtd.2024.100431 · Cited by 8
MDMA-Assisted Therapy for Post-Traumatic Stress Disorder: Regulatory Challenges and a Path Forward
Singh, B. (2025) · CNS Drugs · doi:10.1007/s40263-025-01162-y · Cited by 10
Changing your mind: neuroplastic mechanisms underlying the therapeutic effect of psychedelics in depression, PTSD, and addiction
Palhas, M. L. C., Corne, R., & Mongeau, R. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111533 · Cited by 10
Hallucinogen Use and Misuse in Older Adults
Redden, W. M., Paracha, S.-U.-R., & Sheheryar, Q. (2021) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2021.07.007 · Cited by 8
EMBARK Psychedelic Therapy for Depression
Brennan, B., & Belser, A. (2024) · doi:10.1093/9780197762622.001.0001 · Cited by 8
Effect of MDMA-assisted therapy on mood and anxiety symptoms in advanced-stage cancer (EMMAC): study protocol for a double-blind, randomised controlled trial
Bhagavan, C., Glue, P., Evans, W., Reynolds, L., Turner, T., King, C., Russell, B. R., Morunga, E., Mills, J. L., Layton, G., et al. (2024) · Trials · doi:10.1186/s13063-024-08174-x · Cited by 10
Action-Outcome Expectancies Require Orbitofrontal Neurotrophin Systems in Naïve and Cocaine-Exposed Mice
Pitts, E. G., Barfield, E. T., Woon, E. P., & Gourley, S. L. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00752-1 · Cited by 8
Ecstasy tablets: Rapid identification and determination of enantiomeric excess of MDMA
Fagan, P., Spálovská, D., Kuchař, M., Černohorský, T., Komorousová, L., Kocourková, L., & Setnička, V. (2021) · Forensic Chemistry · doi:10.1016/j.forc.2021.100381 · Cited by 8
Crime and Violence among MDMA Users in the United States
Vaughn, M. G., Salas‐Wright, C. P., DeLisi, M., Perron, B. E., & Córdova, D. (2015) · AIMS Public Health · doi:10.3934/publichealth.2015.1.64 · Cited by 8
Research on psychedelic substances
Brandt, S. D., & Passie, T. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1389 · Cited by 8
“Strengthening the Moral Compass”: The Effects of MDMA (“Ecstasy”) Therapy on Moral and Spiritual Development
McDaniel, J. (2017) · Pastoral Psychology · doi:10.1007/s11089-017-0789-6 · Cited by 8
Pharmacotherapy for PTSD: effects on PTSD symptoms and the brain
Davis, L. L., Hamner, M. B., & Bremner, J. D. (2016) · doi:10.1002/9781118356142.ch16 · Cited by 8
Can Psychedelics be the Treatment for the Crisis in Psychopharmacology?Preprint
Oña, G., & Bouso, J. C. (2019) · Preprints.org · doi:10.20944/preprints201901.0249.v1 · Cited by 8
Psychedelic Therapy: A Primer for Primary Care Clinicians—3,4-Methylenedioxy-methamphetamine (MDMA)
Shinozuka, K., Tabaac, B. J., Arenas, A., Beutler, B. D., Cherian, K. N., Evans, V. D., Fasano, C., & Muir, O. S. (2024) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001722 · Cited by 9
MDMA-assisted therapy and current treatment options for chronic, treatment-resistant, moderate or higher severity post-traumatic stress disorder: Systematic literature review
Stanicic, F., Zah, V., Grbic, D., Vukicevic, D., & de Angelo, D. (2025) · PLoS ONE · doi:10.1371/journal.pone.0327778 · Cited by 8
Beyond Religious Freedom: Psychedelics and Cognitive Liberty
Walsh, C. (2013) · Springer eBooks · doi:10.1007/978-3-642-40957-8_11 · Cited by 8
The Varieties of Ecstasy Experience: A Phenomenological Ethnography
Leneghan, S. (2013) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2013.826561 · Cited by 7
Therapeutic Use of Hallucinogens
Wiltenburg, V. D., Prado, D. D. R., & Mendes, F. (2021) · Springer eBooks · doi:10.1007/978-3-030-62855-0_35 · Cited by 1
Dosing and Therapeutic Conduct in Administration Sessions in Substance-Assisted Psychotherapy: A Systematized Review
Thal, S. B., Wieberneit, M., Sharbanee, J. M., Skeffington, P., Bruno, R., Wenge, T., & Bright, S. J. (2023) · Journal of Humanistic Psychology · doi:10.1177/00221678231168516 · Cited by 9
Can research on entactogens contribute to a deeper understanding of human sexuality?
Holka-Pokorska, J. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00552-7 · Cited by 6
Effects of 3,4-Methylenedioxymethamphetamine on Patient Utterances in a Psychotherapeutic Setting
Corey, V., Pisano, V. D., & Halpern, J. H. (2016) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000499 · Cited by 9
The Pathological Consequences of Exposure to Domestic and Family Violence in Childhood
Sinnamon, G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815344-4.00010-6 · Cited by 7
Amphétamines et dérivés
Ghysel-Laporte, M.-H., Sibille, P., & Milan, N. (2012) · Elsevier eBooks · doi:10.1016/b978-2-294-71561-7.00015-7 · Cited by 7
Neurociencias y aplicaciones psicoterapéuticas en el renacimiento de la investigación con psicodélicos
Timmermann, C. (2014) · Revista chilena de neuro-psiquiatría · doi:10.4067/s0717-92272014000200005 · Cited by 10
Utilisation des psychédéliques en psychiatrie : lien avec les neurotrophines
Corne, R., & Mongeau, R. (2019) · Biologie Aujourd hui · doi:10.1051/jbio/2019015 · Cited by 8

Authors: Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., & Doblin, R.
Affiliations: Private Practice of Psychiatry and Clinical Research, Mount Pleasant SC, USA.
Medical University of South Carolina (US)
Multidisciplinary Association for Psychedelic Studies (US)
Corresponding author: Mithoefer, Michael C
ORCID: Mithoefer, Michael C
Jerome, Lisa
Doblin, Rick
Venue: Journal of Psychopharmacology
Publisher: SAGE Publications
Published: 2010-07-19
Volume: 25
Issue: 4
Pages: 439-452
ISSN: 0269-8811 (ISSN-L)
1461-7285
DOI: 10.1177/0269881110378371
PMC: PMC3122379
OpenAlex: W2089149909
Cited by: 674
References: 67
Citations by year: 2026: 30 · 2025: 36 · 2024: 75 · 2023: 49 · 2022: 52 · 2021: 41 · 2020: 61 · 2019: 62 · 2018: 59 · 2017: 45 · 2016: 28 · 2015: 27 · 2014: 23 · 2013: 44 · 2012: 26
FWCI: 29.42
Type: journal article
Language: en
Update notices: correction (2011-06-01)
Open access: hybrid
doi.org
Licence: cc-by-nc
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations: Journal of Psychopharmacology (publishedVersion, cc-by-nc)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
Keywords: MDMA-assisted psychotherapy, MDMA, 3,4-methylenedioxymethamphetamine, post-traumatic stress disorder, treatment-resistant PTSD, chronic PTSD, psychedelic therapy, Clinician-Administered PTSD Scale, adverse events, neurocognitive effects, blood pressure
MeSH terms: Adult, Aged, Double-Blind Method, Fear, Female, Humans, Male, Middle Aged, Music Therapy, Pilot Projects, Placebos, Psychiatric Status Rating Scales, Psychotherapy, Stress Disorders, Post-Traumatic, Treatment Outcome, Serotonin Agents, Cross-Over Studies, N-Methyl-3,4-methylenedioxyamphetamine, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks